HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor.

AbstractOBJECTIVES AND RATIONALE:
Medulloblastoma/primitive neuroectodermal tumor (MB/PNET) is the most common malignant tumor of the central nervous system (CNS) in children. MB/PNET survivors are at an increased risk for developing second malignancies. Little has been reported on development of low-grade lesions of the calvarium in the radiation field in MB/PNET survivors. The purpose of this study was to assess the frequency of the low-grade bone lesion development in the radiotherapy field in pediatric MB/PNET survivors and describe the imaging characteristics of these lesions.
MATERIALS AND METHODS:
Institutional review board approval was obtained for this retrospective review which was compliant with Health Insurance Portability and Accountability Act. Forty-one MB/PNET patients (29 male) who survived for at least 2 years after initiation of radiation therapy were included. The medical records were reviewed. The most recent available brain magnetic resonance imaging studies were evaluated.
RESULTS:
Three patients (7.3%) developed low-grade calvarial lesions and underwent resection and/or biopsy of the lesions. There were one Langerhans cell histiocytosis, one benign spindle cell lesion with myxoid change, and one fibrous dysplasia.
CONCLUSION:
Development of low-grade bone lesions of calvarium is not very rare in pediatric PNET/MB survivors. Bones in the radiation therapy field need to be carefully examined for assessment of secondary lesions.
AuthorsKorgun Koral, Dave Roy, Charles F Timmons, Lynn Gargan, Daniel C Bowers
JournalAcademic radiology (Acad Radiol) Vol. 19 Issue 1 Pg. 35-9 (Jan 2012) ISSN: 1878-4046 [Electronic] United States
PMID22054800 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2012 AUR. Published by Elsevier Inc. All rights reserved.
Topics
  • Adolescent
  • Brain Neoplasms (epidemiology, pathology)
  • Child
  • Child, Preschool
  • Comorbidity
  • Female
  • Humans
  • Incidence
  • Infant
  • Magnetic Resonance Imaging
  • Male
  • Medulloblastoma (epidemiology, pathology)
  • Neoplasms, Second Primary (epidemiology, pathology)
  • Neuroectodermal Tumors, Primitive (epidemiology, pathology)
  • Risk Assessment
  • Risk Factors
  • Skull Neoplasms (epidemiology, pathology)
  • Survivors
  • Texas (epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: